Janka Tamás, Tornai Dávid, Papp Mária, Vitális Zsuzsanna
Division of Gastroenterology, Department of Internal Medicine, Faculty of Medicine, University of Debrecen, 4032 Debrecen, Hungary.
Kálmán Laki Doctoral School of Biomedical and Clinical Sciences, University of Debrecen, 4032 Debrecen, Hungary.
Diagnostics (Basel). 2023 Sep 14;13(18):2954. doi: 10.3390/diagnostics13182954.
Liver cirrhosis patients are highly susceptible to infections, affecting survival, but current parameters for detecting infection are not reliable enough in this population. We investigated the ability of white blood cell (WBC), ∆WBC, neutrophil and ∆neutrophil counts, neutrophil-to-lymphocyte (NLR) and ∆NLR ratios and C-reactive protein (CRP) and procalcitonin (PCT) levels to identify infection and predict short-term mortality in liver cirrhosis patients. We recruited 233 patients with liver cirrhosis hospitalized with acute decompensation (AD) who had an outpatient visit within 1 month (baseline laboratory data) and followed them for 90 days. Difference between laboratory values at baseline and the AD episode was defined as delta (∆) values of the parameters. Delta values did not increase the diagnostic and predictive ability of investigated parameters. The CRP level was found to be the best diagnostic marker for infection in patients with cirrhosis. However, NLR seems to be superior for short-term mortality prediction, better than the WBC count. Distinguishing inflammations of different origin is a remaining clinical challenge in acutely decompensated cirrhosis. Based on our results, NLR might be more suitable for predicting short-term mortality in patients with AD than the WBC count currently included in the CLIF-C AD score.
肝硬化患者极易感染,这会影响其生存,但目前用于检测感染的指标在该人群中不够可靠。我们研究了白细胞(WBC)、∆WBC、中性粒细胞和∆中性粒细胞计数、中性粒细胞与淋巴细胞比值(NLR)和∆NLR比值以及C反应蛋白(CRP)和降钙素原(PCT)水平在识别肝硬化患者感染及预测短期死亡率方面的能力。我们招募了233例因急性失代偿(AD)住院的肝硬化患者,这些患者在1个月内进行了门诊就诊(基线实验室数据),并对他们进行了90天的随访。基线和AD发作时实验室值的差异定义为参数的delta(∆)值。∆值并未提高所研究参数的诊断和预测能力。发现CRP水平是肝硬化患者感染的最佳诊断标志物。然而,NLR在预测短期死亡率方面似乎更具优势,优于白细胞计数。区分不同来源的炎症是急性失代偿性肝硬化中尚存的临床挑战。基于我们的研究结果,对于AD患者,NLR可能比目前CLIF-C AD评分中包含的白细胞计数更适合预测短期死亡率。